NGM · Financial Statements

Protagonist Therapeutics, Inc. (PTGX) Financial Statements

$143.73 NGM: PTGX Market Cap $9.24B

Protagonist Therapeutics, Inc. most recently reported annual revenue of $46.0M, net profit of $-130.0M, revenue has compounded at 9.7% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$27.0M$27.0M$60.0M$434.0M$46.0M
Operating Profit$-126.0M$-131.0M$-94.0M$253.0M$-158.0M
Net Profit$-126.0M$-127.0M$-79.0M$275.0M$-130.0M
EPS$-2.65$-2.52$-1.39$4.23$-2.05
Op Margin-460.0%-494.2%-156.1%58.2%-343.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$348.0M$248.0M$358.0M$745.0M$670.0M
Total Liabilities$48.0M$32.0M$21.0M$69.0M$55.0M
Cash$124.0M$126.0M$187.0M$97.0M$128.0M
Borrowings$6.0M$4.0M$1.0M$11.0M$10.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-108.0M$-108.0M$-70.0M$184.0M$58.0M
Investing Cash Flow$-17.0M$91.0M$-40.0M$-301.0M$-51.0M
Financing Cash Flow$6.0M$4.0M$38.0M$-1.0M$0
Net Cash Flow$6.0M$2.0M$61.0M$-89.0M$31.0M
Free Cash Flow$-109.0M$-109.0M$-71.0M$183.0M$56.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.14
EV / EBITDA101.19
FCF Yield1.46%
Quick Ratio21.71
Interest Coverage0.00
Return 1Y116.92%
Return 3Y765.95%
Return 5Y695.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
PTGX Overview PTGX Dividend Run Stock Screener